Published in Cancer on February 15, 1993
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res (2009) 2.42
Diagnostic and prognostic values of S-phase fraction and aneuploidy in patients with bone marrow aplasia. Indian J Hematol Blood Transfus (2009) 0.75
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol (1988) 3.92
Gynaecomastia with cimetidine. Lancet (1977) 2.04
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther (1994) 1.79
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol (1994) 1.79
Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation (1998) 1.73
Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res (2000) 1.70
Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses. Biochem Soc Trans (2004) 1.49
Metastasizing dermal squamomelanocytic tumour: more evidences. J Eur Acad Dermatol Venereol (2011) 1.46
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer (2000) 1.33
An ambulance referral network improves access to emergency obstetric and neonatal care in a district of rural Burundi with high maternal mortality. Trop Med Int Health (2013) 1.33
The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem (1994) 1.32
Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res (1986) 1.24
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Oncol (2005) 1.22
Dysregulation of calcium homeostasis after severe burn injury in children: possible role of magnesium depletion. J Pediatr (1997) 1.22
Achieving the millennium development goal of reducing maternal mortality in rural Africa: an experience from Burundi. Trop Med Int Health (2012) 1.17
Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett (2000) 1.15
Vesicocolonic fistulas in diverticulitis. J Urol (1976) 1.12
Neonatal problems of late and moderate preterm infants. Semin Fetal Neonatal Med (2012) 1.12
Hormone-modulated rRNA gene activity is visualized by selective staining of the NOs. Cell Biol Int Rep (1985) 1.12
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur J Cancer (1993) 1.10
Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab (1998) 1.10
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. J Hepatol (1996) 1.09
p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation. Oncogene (2010) 1.09
Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br J Cancer (1994) 1.08
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. Bone Marrow Transplant (2009) 1.07
Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal. Eur J Endocrinol (2007) 1.06
Microdeletions in interval 6 of the Y chromosome detected by STS-PCR in 6 of 33 patients with idiopathic oligo- or azoospermia. Cytogenet Cell Genet (1996) 1.03
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J Pathol (2001) 1.01
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. Oncogene (2011) 0.99
Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int J Cancer (2001) 0.99
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant (2005) 0.98
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig Dis Sci (1999) 0.97
Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients. Breast Cancer Res Treat (1988) 0.95
Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines. FEBS Lett (1993) 0.95
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. Ann Oncol (2006) 0.94
90K (Mac-2 BP) in human milk. Clin Exp Immunol (1996) 0.94
Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res (1995) 0.93
Atherosclerosis: a classic inflammatory disease. Int J Immunopathol Pharmacol (2012) 0.93
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer. Int J Cancer (1996) 0.91
Miliary tuberculosis of the lung in a patient treated with bacillus Calmette-Guerin for superficial bladder cancer. J Urol (1998) 0.91
90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (1993) 0.90
Biochemistry of cervical mucus: a comparative analysis of the secretion from preovulatory, postovulatory, and pregnancy periods. Fertil Steril (1971) 0.90
Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children. J Clin Immunol (2000) 0.90
Necrotizing pneumonia caused by Penicillium chrysogenum. J Clin Microbiol (1997) 0.90
Induced protein synthesis and oestradiol binding to the nuclei in the rat uterus. Nat New Biol (1973) 0.90
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. Ann Oncol (2012) 0.89
Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study. J Clin Oncol (2004) 0.89
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. Br J Cancer (2010) 0.89
A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men. AIDS Res Hum Retroviruses (1993) 0.89
Recombinant human leukocyte interferon-alpha 2b stimulates the synthesis and release of a 90K tumor-associated antigen in human breast cancer cells. Int J Cancer (1988) 0.89
The effect of parenteral nitrogen and energy intake on electrolyte balance in the preterm infant. Eur J Clin Nutr (2011) 0.88
Unknown primary tumors. Biochim Biophys Acta (2011) 0.88
Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo. Blood (2000) 0.88
Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines. J Cancer Res Clin Oncol (1988) 0.88
p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation. Oncogene (2011) 0.88
Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections. Clin Exp Immunol (1999) 0.88
90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells. Int J Cancer (1998) 0.88
Epidermal growth factor receptor expression in gynecological malignancies. Gynecol Obstet Invest (1989) 0.88
Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line. Breast Cancer Res Treat (1983) 0.87
A quarter of men with idiopathic oligo-azoospermia display chromosomal abnormalities and microdeletions of different types in interval 6 of Yq11. Hum Genet (1998) 0.87
Human H1 histones: conserved and varied sequence elements in two H1 subtype genes. Eur J Cell Biol (1989) 0.87
Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial. Neonatology (2006) 0.87
The role of hypoxia in erectile dysfunction mechanisms. Int J Impot Res (2007) 0.87
Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease. Br J Cancer (1993) 0.87
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. Cancer Res (1991) 0.86
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding study. Oncol Rep (2006) 0.85
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study. Oncol Rep (2010) 0.85
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. Am J Gastroenterol (1998) 0.85
A novel cationic amphiphile for transfection of mammalian cells. Biochem Biophys Res Commun (1994) 0.85
Glutathione transferase isoenzymes in normal and neoplastic human kidney tissue. Carcinogenesis (1991) 0.85
Human renal cell carcinoma as a hormone-dependent tumor. Cancer Res (1978) 0.85
Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients. Br J Haematol (1993) 0.85
Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial. Dig Liver Dis (2003) 0.85
Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb (1994) 0.85
Carcinosarcoma and separate neuroendocrine malignant tumor of a malignancy promoter, the gastric stump. Anticancer Res (1994) 0.84
90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L. Arch Pathol Lab Med (1998) 0.84
Recombinant alpha-2b-interferon dynamic test as a potential tool in predicting disease status during second look in ovarian cancer. A preliminary report. Cancer (1991) 0.84
[Primary malignant schwannoma of the uterine cervix: a malignant tumor with unusual behaviour. A case report]. Pathologica (2005) 0.84
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study. J Clin Oncol (1991) 0.84